Skip to content

AYTU BIOPHARMA, INC: filings

Every AYTU BIOPHARMA, INC annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-05-13fiscal Q3 2026511480001437749-26-016721
10-Q2026-02-03fiscal Q2 2026511440001437749-26-002804
10-Q2025-11-13fiscal Q1 2026511040001437749-25-034825
10-K2025-09-23fiscal FY 202549990001437749-25-029723
10-Q2025-05-14fiscal Q3 2025501460001437749-25-016833
10-Q2025-02-12fiscal Q2 2025491400001437749-25-003568
10-Q2024-11-13fiscal Q1 2025481000001437749-24-034970
10-K2024-09-26fiscal FY 2024501000001437749-24-030062
10-Q2024-05-15fiscal Q3 2024471330001437749-24-017051
10-Q2024-02-14fiscal Q2 2024471290001437749-24-004149
10-Q2023-11-14fiscal Q1 202447970001558370-23-019015
10-K2023-10-12fiscal FY 2023531080001558370-23-016393
10-Q2023-05-11fiscal Q3 2023491440001558370-23-009367
10-Q2023-02-21fiscal Q2 2023501420001558370-23-001645
10-Q/A2023-02-21fiscal Q1 2023501030001558370-23-001643
10-Q2022-11-14fiscal Q1 2023501030001558370-22-017751
10-K2022-09-27fiscal FY 2022531080001558370-22-014652
10-Q2022-05-16fiscal Q3 2022511420001558370-22-008952
10-Q2022-02-14fiscal Q2 2022501380001558370-22-001110
10-Q2021-11-15fiscal Q1 2022501010001558370-21-015996
10-K2021-09-28fiscal FY 202150960001558370-21-012825
10-Q2021-05-17fiscal Q3 2021431110001437749-21-012543
10-Q2021-02-11fiscal Q2 2021421040001437749-21-002627
10-Q2020-11-12fiscal Q1 202143870001654954-20-012265
10-K2020-10-06fiscal FY 202043860001654954-20-010891
10-Q2020-05-15fiscal Q3 2020431150001654954-20-005522
10-Q2020-02-14fiscal Q2 2020421090001654954-20-001622
10-Q2019-11-14fiscal Q1 202039790001654954-19-013026
10-K2019-09-26fiscal FY 202038770001654954-19-011147
10-Q2019-05-14fiscal Q3 2019381080001654954-19-005839
10-Q2019-05-14fiscal Q2 201937940001654954-19-005834
10-Q2019-02-07fiscal Q2 201937940001654954-19-001148
10-Q2018-11-07fiscal Q1 201936690001213900-18-015059
10-K2018-09-06fiscal FY 201839760001213900-18-012209
10-Q2018-05-14fiscal Q3 201837940001213900-18-006106
10-Q2018-02-08fiscal Q2 201835870001213900-18-001446
10-Q2017-11-09fiscal Q1 201835690001213900-17-011671
10-K2017-08-31fiscal FY 201737760001144204-17-046061
10-Q2017-05-11fiscal Q3 201734900001144204-17-026452
10-Q2017-02-09fiscal Q2 201732880001144204-17-007057
10-Q2016-11-07fiscal Q1 201732660001144204-16-132071
10-K2016-09-01fiscal FY 201636750001144204-16-122393
10-Q2016-05-11fiscal Q3 201632880001144204-16-100633
10-Q2016-02-11fiscal Q2 201632880001144204-16-080521
10-Q2015-11-06fiscal Q1 201531600001193125-15-370153
10-K2015-09-28fiscal FY 201530550001193125-15-333046
10-Q2015-05-19fiscal Q3 201528690001193125-15-193527
10-Q2015-04-15fiscal Q2 201518470001079974-15-000272
10-Q2015-01-12fiscal Q1 201518370001079974-15-000022
10-K2014-11-26fiscal FY 201320620001079974-14-000837
10-Q2014-07-10fiscal Q3 201420750001079974-14-000542
10-Q2014-04-11fiscal Q2 201420740001079974-14-000265
10-Q2014-01-10fiscal Q1 201420640001079974-14-000015
10-K2013-11-26fiscal FY 201320620001079974-13-000764
10-Q2013-06-28fiscal Q3 201319700001079974-13-000336
10-Q2013-04-15fiscal Q2 201319700001079974-13-000195
10-Q2013-01-14fiscal Q1 201319600001079974-13-000012
10-K2012-11-29fiscal FY 201220600001079974-12-000632
10-Q2012-06-26fiscal Q3 201219690001079974-12-000288
10-Q2012-04-12fiscal Q2 201219690001079974-12-000137
10-Q2011-12-23fiscal Q1 201219630001354488-11-005179

Inspect the source

Entity
AYTU BIOPHARMA, INC / CIK 0001385818
Captured
2026-09-20T07:58:53.461Z
SEC response SHA-256
3b664ab8156647d48cbdda6c8eb0b5f1ac4147c50f45c9bb53fa74b58565a69b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001385818.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))